Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2153 - 2160 of 11617 results
Fintiv in Decline?
February 17, 2022| Blog| Viewpoint
Hughes v. Northwestern University: Lessons for Retirement Committees and Other Fiduciaries
February 16, 2022| Blog| Viewpoint
Keep Out: Uniloc Gets Second Chance to Seal Licensing Documents
February 16, 2022| Blog| Viewpoint
Webinar Recording: Health Care Enforcement Year in Review & 2022 Outlook
February 16, 2022| Webinar| Viewpoint
Uniloc Gets Second Chance to Seal Licensing Documents
February 16, 2022| News
A Sex Trafficking Survivor Gets Help to Move On
February 14, 2022| Article| Viewpoint
Impact of Recent OSHA and CDC Updates on Employers’ Mandatory Vaccination Policies
February 14, 2022| Blog| Viewpoint
Health Care Enforcement Year in Review & 2022 Outlook
February 11, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.